Real-world use of oral versus subcutaneous semaglutide in a cohort of type 2 diabetic patients: which option to which patient?

Autor: Formichi, C., Baronti, W., de Gennaro, G., Cerrai Ceroni, M., Nigi, L., Rizzo, L., Dotta, F.
Zdroj: Journal of Endocrinological Investigation; Nov2024, Vol. 47 Issue 11, p2679-2690, 12p
Databáze: Complementary Index
Externí odkaz: